Patient Guide: A Phase 1/2, First-Time-in Human (FTiH), randomized, observer-blind, placebo-controlled, dose escalation study to assess safety, reactogenicity and immunogenicity of a candidate cytomegalovirus (CMV) vaccine comprising recombinant protein and adjuvant when administered intramuscularly in healthy adults

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 18 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05089630
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Cytomegalovirus Infections
Phase: Phase I, Phase II

Find a Study Location Near You

This study is available at 18 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Miami, FL
  • Austin, TX
  • Cedar Park, TX
  • • And 15 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily